Inventor · disambiguated record
Dustin Mcminn
Also filed as: MCMINN DUSTIN · MCMINN DUSTIN L
36 granted patents·12 pending applications·189 citations·filing 2002–2024
96Inventor score
Files withAMGEN INC15KEZAR LIFE SCIENCES10BEREN THERAPEUTICS P B C5ONYX THERAPEUTICS INC5GENESOFT PHARMACEUTICALS INC4
Top patents by PatentIndex Score
48 records- 0193US11958917B2Compositions of hydroxypropyl-beta-cyclodextrin and methods of purifying the sameBEREN THERAPEUTICS P B C·Filed 2023·Granted Apr 16, 2024·12 cites·33 claims
- 0293US7199119B2Antiinflammation agentsAMGEN INC·Filed 2003·Granted Apr 3, 2007·75 cites·11 claims
- 0391US12215174B2Compositions of hydroxypropyl-β-cyclodextrin and methods of purifying the sameBEREN THERAPEUTICS P B C·Filed 2024·Granted Feb 4, 2025·2 cites·28 claims
- 0490US12168701B2Compositions of hydroxypropyl-beta-cyclodextrin and methods of purifying the sameBEREN THERAPEUTICS P B C·Filed 2023·Granted Dec 17, 2024·1 cites·13 claims
- 0590US9434761B2Tripeptide epoxy ketone protease inhibitorsONYX THERAPEUTICS INC·Filed 2014·Granted Sep 6, 2016·13 cites·20 claims
- 0688US9593129B2Piperidinone derivatives as MDM2 inhibitors for the treatment of cancerAMGEN INC·Filed 2016·Granted Mar 14, 2017·5 cites·18 claims
- 0788US9296736B2Piperidinone derivatives as MDM2 inhibitors for the treatment of cancerAMGEN INC·Filed 2014·Granted Mar 29, 2016·7 cites·13 claims
- 0887US12509531B2Compositions of hydroxypropyl-beta-cyclodextrin and methods of purifying the sameBEREN THERAPEUTICS P B C·Filed 2024·Granted Dec 30, 2025·0 cites·16 claims
- 0987US2024300892A1Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of CancerAMGEN INC·Filed 2023·Application pending·0 cites
- 1086US7635695B2Antiinflammation agentsAMGEN INC·Filed 2007·Granted Dec 22, 2009·10 cites·20 claims
- 1185US12258426B2Compositions of hydroxypropyl-beta-cyclodextrin and methods of purifying the sameBEREN THERAPEUTICS P B C·Filed 2024·Granted Mar 25, 2025·0 cites·19 claims
- 1284US11498907B2Process of preparing a peptide epoxyketone immunoproteasome inhibitor, and precursors thereofKEZAR LIFE SCIENCES·Filed 2020·Granted Nov 15, 2022·1 cites·7 claims
- 1383US7244727B2Fused bicyclic nitrogen-containing heterocyclesJAPAN TOBACCO INC·Filed 2003·Granted Jul 17, 2007·22 cites·57 claims
- 1482US8153633B2Phthalazine compounds, compositions and methods of useAUSTIN RICHARD J·Filed 2008·Granted Apr 10, 2012·7 cites·27 claims
- 1580US10781192B2Process of preparing a peptide epoxyketone immunoproteasome inhibitor, and precursors thereofKEZAR LIFE SCIENCES·Filed 2017·Granted Sep 22, 2020·1 cites·20 claims
- 1680US8841312B2Fused pyridine, pyrimidine and triazine compounds as cell cycle inhibitorsCONNORS RICHARD V·Filed 2008·Granted Sep 23, 2014·6 cites·35 claims
- 1780US6716866B2Aryl-benzimidazole compounds having antiinfective activityGENESOFT PHARMACEUTICALS INC·Filed 2002·Granted Apr 6, 2004·10 cites·42 claims
- 1880US2022169611A1Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of CancerAMGEN INC·Filed 2022·Application pending·0 cites
- 1979US11891383B2Crystalline salts of peptide epoxyketone immunoproteasome inhibitorKEZAR LIFE SCIENCES·Filed 2022·Granted Feb 6, 2024·0 cites·18 claims
- 2079US10647744B2Tripeptide epoxy ketone protease inhibitorsONYX THERAPEUTICS INC·Filed 2016·Granted May 12, 2020·2 cites·38 claims
- 2179US7605289B2Benzamide derivatives and uses related theretoAMGEN INC·Filed 2006·Granted Oct 20, 2009·4 cites·42 claims
- 2278US7402704B2Arylsulfones and uses related theretoAMGEN INC·Filed 2005·Granted Jul 22, 2008·3 cites·18 claims
- 2374US11976053B2Process of preparing a peptide epoxyketone immunoproteasome inhibitor, and precursors thereofKEZAR LIFE SCIENCES·Filed 2022·Granted May 7, 2024·0 cites·20 claims
- 2474US2021179560A1Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of CancerAMGEN INC·Filed 2020·Application pending·0 cites
- 2573US9657057B2Dipeptide and tripeptide epoxy ketone protease inhibitorsONYX THERAPEUTICS INC·Filed 2014·Granted May 23, 2017·2 cites·21 claims
- 2669US11479548B2Crystalline salts of peptide epoxyketone immunoproteasome inhibitorKEZAR LIFE SCIENCES·Filed 2020·Granted Oct 25, 2022·0 cites·9 claims
- 2769US11078233B2Tripeptide epoxy ketone protease inhibitorsONYX THERAPEUTICS INC·Filed 2020·Granted Aug 3, 2021·0 cites·27 claims
- 2869US7498349B2Biaryl compounds having anti-infective activityGENESOFT PHARMACEUTICALS INC·Filed 2003·Granted Mar 3, 2009·4 cites·13 claims
- 2967US2019062276A1Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of CancerAMGEN INC·Filed 2018·Application pending·0 cites
- 3066US8222251B2Pyridopyridazine compounds, compositions and methods of useKAIZERMAN JACOB·Filed 2008·Granted Jul 17, 2012·1 cites·32 claims
- 3165US10836756B2Crystalline salts of peptide epoxyketone immunoproteasome inhibitorKEZAR LIFE SCIENCES·Filed 2017·Granted Nov 17, 2020·0 cites·20 claims
- 3265US2014011796A1Piperidinone derivatives as mdm2 inhibitors for the treatment of cancerAMGEN INC·Filed 2013·Application pending·0 cites
- 3364US2017144971A1Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of CancerAMGEN INC·Filed 2017·Application pending·0 cites
- 3463USRE47302EPeptide epoxyketone immunoproteasome inhibitorsONYX THERAPEUTICS INC·Filed 2017·Granted Mar 19, 2019·0 cites·31 claims
- 3563US7265129B2Anti-infective biaryl compoundsGENESOFT PHARMACEUTICALS INC·Filed 2003·Granted Sep 4, 2007·1 cites·24 claims
- 3660US2008090816A1Anti-infective biaryl compoundsGENESOFT PHARMACEUTICALS INC·Filed 2007·Application pending·0 cites
- 3759US8637576B2Benzamide derivatives and uses related theretoPOWERS JAY P·Filed 2009·Granted Jan 28, 2014·0 cites·4 claims
- 3859US2025171434A1Sec61 inhibitors and use thereofKEZAR LIFE SCIENCES INC·Filed 2023·Application pending·0 cites
- 3958US7754890B2Arylsulfones and uses related theretoAMGEN INC·Filed 2008·Granted Jul 13, 2010·0 cites·11 claims
- 4054US8980903B2Fused pyridine, pyrimidine and triazine compounds as cell cycle inhibitorsAMGEN INC·Filed 2014·Granted Mar 17, 2015·0 cites·22 claims
- 4152US7932421B2N-cyclohexyl benzamides and benzeneacetamides as inhibitors of 11-beta-hydroxysteroid dehydrogenasesAMGEN INC·Filed 2007·Granted Apr 26, 2011·0 cites·26 claims
- 4252US2007244096A1Fused Bicyclic Nitrogen-Containing HeterocyclesJAPAN TOBACCO INC·Filed 2007·Application pending·0 cites
- 4350US2023286973A1Protein secretion inhibitorsKEZAR LIFE SCIENCES·Filed 2021·Application pending·0 cites
- 4445US2020276204A1Combination therapy for immunological diseasesKEZAR LIFE SCIENCES·Filed 2018·Application pending·0 cites
- 4544US11339193B2CDP protein secretion inhibitorsKEZAR LIFE SCIENCES·Filed 2019·Granted May 24, 2022·0 cites·20 claims
- 4644US8772296B2Benzamide derivatives and uses related theretoPOWERS JAY P·Filed 2007·Granted Jul 8, 2014·0 cites·23 claims
- 4744US2022153732A1Protein secretion inhibitorsKEZAR LIFE SCIENCES·Filed 2020·Application pending·0 cites
- 4843US8076376B2Aniline sulfonamide derivatives and their usesPOWERS JAY P·Filed 2006·Granted Dec 13, 2011·0 cites·23 claims
Join the waitlist — get patent alerts
Get an alert when Dustin Mcminn files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →